Profiles

1.	Tempany CMC, Keeling NPW. Review of our ERCP experiences. 1984.
2.	Tempany C. Villous adenomas of the gastrointestinal tract Part I. Illinois Medical Journal. 1985; 168(5):313-353.
3.	Tempany C. Villous tumor. IMJ Ill Med J. 1985 Nov; 168(5):313, 352-3.
4.	Tempany C. Villous adenomas of the gastrointestinal tract Part II. Illinois Medical Journal. 1986; 169(1):7-45.
5.	Posniak HV, Tempany C, Demos TC, Love L. Computed tomography of posterior pararenal and properitoneal metastases. Urol Radiol. 1988; 10(2):75-9.
6.	Cooper RA, Tempany CM, Farrell B. Conventional and computed tomographic sialography in evaluating disorders of the parotid gland. Entechnology. 1988 Sep; 20-35.
7.	Rahmouni A, Tempany CMC, Zerhouni EA. . The role of MRI analysis of tissue signal intesity in the management of lymphomas. International Congress of Radiology. 1989.
8.	Tempany C, Zerhouni EA, Epstein JI, Walsh PC. Evaluation of the role of MRI in predicting capsular penetration to the neurovascular bundle by prostate cancer. SMRM/RSNA. 1989.
9.	Tempany CMC, Rahmouni A, Mann R, Jones R, Zerhouni EA. MRI in lymphoma-direct patholological correlation. RSNA. 1989.
10.	Templeton P, Tempany CMC, Yang A, Zerhouni E. MR imaging in the assessment of mediastinal venous thrombosis. RSNA. 1989.
11.	Brem R, Tempany CMC, Yang A, Carter B, Epstein JI, Walsh P, Zerhouni EA. Magnetic Resonance Imaging in the detection of occult prostate cancer. SMRI, AUA, RSNA. 1990.
12.	Frostenson P, Tempany CMC, Herold CL, Rosenshein N, Zerhouni EA. The role of MRI in the management of gestational trophoblastic disease. ARRS, RSNA. 1990.
13.	Frostenson PJ, Herold CJ, Tempany CMC, Hsu J, Fishman EK, Zerhouni EA. Spectrum of MR imaging findings of peripheral neurofibromatosis. RSNA. 1990.
14.	Olson M, Posniak H, Tempany CMC, Dudiak C, Gomes G. MR imaging of the female pelvis. 1990.
15.	Parravano JG, Wolff K, Frostenson PJ, Tempany CMC, Pyeritz RE, Zerhouni EA. Pre and postoperative assessment of the aorta and pulmonary arteries in the Marfan patient. 1990.
16.	Tempany CMC, Morton R, Parravano JJ, Zinereich, Zerhouni EA. MR imaging of the renal veins: assessment of venous thrombosis. 1990.
17.	Tempany CMC, Zerhouni EA, Epstein JI, Walsh PC. Neurovascular bundle indentification and invasion by prostate cancer: comparison of MR imaging with conventional body and endorectal coil techniques. RSNA. 1990.
18.	Tempany CMC, Zerhouni EA. Clinical magnetic resonance imaging of the vascular system. Top Magn Reson Imag. 1990; 2(2):13-30.
19.	Wolff KA, Herold CJ, Tempany CMC, Parravano JG, Zerhouni EA. Aortic Dissection: atypical patterns seen at MR imaging. RSNA. 1990.
20.	Tempany CM, Zerhouni EA. Clinical magnetic resonance imaging of the vascular system. Top Magn Reson Imaging. 1990 Mar; 2(2):13-30.
21.	Evaluation of MRI and H-1 spectroscopic correlates with age-associated changes of spontaneous benign prostatic hyperplasia (BPH) in a canine model. RSNA. 1991.
22.	Imanishi Y, Hou V, Chako AC, Zerhouni EA, Tempany CMC. Evaluation of the pancreas by MR imaging. 1991.
23.	Kawashima A, Kuhlman JE, Fishman EK, Tempany CM, Magid D, Lederman HM, Winkelstein JA, Zerhouni EA. Pulmonary Aspergillus chest wall involvement in chronic granulomatous disease: CT and MRI findings. Skeletal Radiol. 1991; 20(7):487-93.
24.	Non-invasive diagnosis of renal vein thrombosis. AUA, Journal of Urology. 1991.
25.	Carter HB, Brem RF, Tempany CM, Yang A, Epstein JI, Walsh PC, Zerhouni EA. Nonpalpable prostate cancer: detection with MR imaging. Radiology. 1991 Feb; 178(2):523-5.
26.	Kronthal AJ, Kang YS, Fishman EK, Jones B, Kuhlman JE, Tempany CM. MR imaging in sclerosing mesenteritis. AJR Am J Roentgenol. 1991 Mar; 156(3):517-9.
27.	Tempany CM, Rahmouni AD, Epstein JI, Walsh PC, Zerhouni EA. Invasion of the neurovascular bundle by prostate cancer: evaluation with MR imaging. Radiology. 1991 Oct; 181(1):107-12.
28.	Kawashima A, Fishman EK, Hruban RH, Tempany CM, Kuhlman JE, Zerhouni EA. Biliary cystadenoma with intratumoral bleeding: radiologic-pathologic correlation. J Comput Assist Tomogr. 1991 Nov-Dec; 15(6):1035-8.
29.	Wolff KA, Herold CJ, Tempany CM, Parravano JG, Zerhouni EA. Aortic dissection: atypical patterns seen at MR imaging. Radiology. 1991 Nov; 181(2):489-95.
30.	Brem RF, Tempany CM, Zerhouni EA. MR detection of breast implant rupture. J Comput Assist Tomogr. 1992 Jan-Feb; 16(1):157-9.
31.	Mitchell DG, Palazzo J, Hann HW, Park CH, Tempany C, Chako A, Rubin R. Mass-like hepatic hypertrophy: MRI findings with histologic correlation. Magn Reson Imaging. 1992; 10(4):541-7.
32.	Saeki M, Pitt HA, Tempany CMC. MRI of hilar cholangiocarcinoma. 1992.
33.	Schiebler ML, Yankaskas BC, Tempany C, Spritzer CE, Rifkin MD, Pollack HM, Holtz P, Zerhouni EA. MR imaging in adenocarcinoma of the prostate: interobserver variation and efficacy for determining stage C disease. AJR Am J Roentgenol. 1992 Mar; 158(3):559-62; discussion 563-4.
34.	Olson MC, Posniak HV, Tempany CM, Dudiak CM. MR imaging of the female pelvic region. Radiographics. 1992 May; 12(3):445-65.
35.	Schiebler ML, Yankaskas BC, Tempany C, Holtz P, Zerhouni E. Efficacy of prostate-specific antigen and magnetic resonance imaging in staging stage C adenocarcinoma of the prostate. Invest Radiol. 1992 Aug; 27(8):575-7.
36.	Rahmouni A, Yang A, Tempany CM, Frenkel T, Epstein J, Walsh P, Leichner PK, Ricci C, Zerhouni E. Accuracy of in-vivo assessment of prostatic volume by MRI and transrectal ultrasonography. J Comput Assist Tomogr. 1992 Nov-Dec; 16(6):935-40.
37.	Silverman SG, Bloom DA, Seltzer SE, Tempany CM, Adams DF. Needle-tip localization during CT-guided abdominal biopsy: comparison of conventional and spiral CT. AJR Am J Roentgenol. 1992 Nov; 159(5):1095-7.
38.	Tempany CM, Morton RA, Marshall FF. MRI of the renal veins: assessment of nonneoplastic venous thrombosis. J Comput Assist Tomogr. 1992 Nov-Dec; 16(6):929-34.
39.	Computed Tomography and MRI in the staging of colorectal carcinoma: Report of the Radiologic Diagnostic Oncology Group. RSNA. 1993.
40.	Imanishi Y, Hou V, Chako AC, Herold CJ, Tempany CMC, Mitsuhashi H, Masuoka M, Fujikawa M, Zerhouni EA. Pseudothrombus in the inferior vena cava near the renal vein on gradient echo image (GRASS). Jpn J Med Imaging. 1993; 12(2):163-169.
41.	MR imaging and sonography of early prostate cancer: Pathologic and imaging features that influence identification and diagnosis. RSNA. 1993.
42.	Schwartz LH, Seltzer SE, Adams DF, Tempany CMC, Piwinica-Worms D, Silverman SG, Herman L, Herman LT, Hooshmand R. . Effects of super paramagentic iron oxide (AMI-25) on liver and spleen imaging using conventional and fast spin echo pulse sequences. CMR. 1993.
43.	Schwartz LH, Seltzer SE, Tempany CMC, Silverman SG, Piwnica-Worms D, Adams DF, Herman L, Hooshmand R. Evaluation of AMI-25, a super paramagnetic iron oxide contrast agent, with conventional and fast spin echo pulse sequences. 1993.
44.	Staging of prostate cancer with MRI: Results of radiology diagnostic oncology group project: comparison of different techniques, including the endorectal coil. RSNA. 1993.
45.	Tempany CM, Partin AW, Zerhouni EA, Zinreich SJ, Walsh PC. The influence of finasteride on the volume of the peripheral and periurethral zones of the prostate in men with benign prostatic hyperplasia. Prostate. 1993; 22(1):39-42.
46.	Tempany CMC. Detection and staging of prostate cancer. Post Graduate Radiology. 1993; (13):171-189.
47.	Rahmouni A, Tempany C, Jones R, Mann R, Yang A, Zerhouni E. Lymphoma: monitoring tumor size and signal intensity with MR imaging. Radiology. 1993 Aug; 188(2):445-51.
48.	Schwartz LH, Seltzer SE, Tempany CM, Silverman SG, Piwnica-Worms DR, Adams DF, Herman L, Herman LT, Hooshmand R. Prospective comparison of T2-weighted fast spin-echo, with and without fat suppression, and conventional spin-echo pulse sequences in the upper abdomen. Radiology. 1993 Nov; 189(2):411-6.
49.	Imanishi Y, Hou V, Chako AC, Tempany CMC, Herold CJ, Zerhouni EA. Evaluation of the Pancreas by MRI. European Radiology. 1994; 4:243-253.
50.	Tempany CMC, Bastier E, Corless C, Silverman SG, Loughlin KR. MR imaging of biopsy proven prostate cancer. 1994.
51.	Wax JR, Kuhlman JE, Callan NA, Tempany CMC, Johnson TRB. Magnetic Resonance Imaging of the third trimester fetal lung. J Maternal-Fetal Invest. 1994; 4:73-75.
52.	Ellis JH, Tempany C, Sarin MS, Gatsonis C, Rifkin MD, McNeil BJ. MR imaging and sonography of early prostatic cancer: pathologic and imaging features that influence identification and diagnosis. AJR Am J Roentgenol. 1994 Apr; 162(4):865-72.
53.	Schwartz LH, Seltzer SE, Adams DF, Tempany CM, Piwnica-Worms DR, Silverman SG, Herman L, Herman LT, Hooshmand R. Effects of superparamagnetic iron oxide (AMI-25) on liver and spleen imaging using spin-echo and fast spin-echo magnetic resonance pulse sequences. Invest Radiol. 1994 Jun; 29 Suppl 2:S21-3.
54.	Tempany CM, Zhou X, Zerhouni EA, Rifkin MD, Quint LE, Piccoli CW, Ellis JH, McNeil BJ. Staging of prostate cancer: results of Radiology Diagnostic Oncology Group project comparison of three MR imaging techniques. Radiology. 1994 Jul; 192(1):47-54.
55.	A temporal analysis of postoperative PSA failure in patients with positive surgical margins; implications on the use of adjuvant therapy. New England AUA. 1995.
56.	Brown DL, Silverman SG, Tempany CMC. Ovarian and adnexal diseases. MR and Imaging of the Female Pelvis. 1995; 185-234..
57.	Evaluation of endorectal coil in the prediction of surgical margin status after radical prostatectomy. RSNA. 1995.
58.	Fielding JR, Morton RA, Tempany CMC. Congenital and pediatric disorders of the Mullerian and genitourinary system. MR and Imaging of the Female Pelvis. 1995; 75-104.
59.	High resolution MRI of breast fibroadenomas using T2-weighted fat saturated FSE imaging. AUR. 1995.
60.	Horton KM, Tempany CMC. MRI in pregnancy. MR and Imaging of the Female Pelvis. 1995; 235-260.
61.	Hutcheson J, Tempany CMC, Sica GT, Loughlin K. MRI in evaluation of penile cancer. 1995.
62.	Mok PL, Pomeroy OH, Tempany CMC, Adams DA, Frenna T. MR imaging of breast specimens. 1995.
63.	MR imaging of breast specimens. AUR. 1995.
64.	Pomeroy OH, Mok P, Lester S, Adams DA, Tempany CMC, Jolesz FA. Gadolinium enhanced MRI of core biopsy proven fibroadenomas: histological correlation. 1995.
65.	Pomeroy OH, Tempany CMC, Hiramatsu H, Frenna TH, Koichi O, Jolesz FA. High resolution MRI of breast fibroadenomas using T2 weighted fat sat. 1995.
66.	Small hyperechoic renal masses: comparison of spiral and conventional CT for the diagnosis of angiomyolipoma. ARRS. 1995.
67.	Tempany CMC, Gatsonis C, Mc Neil BJ. Devil's Advocate "Staging of prostate cancer: Accuracy of MR Imaging" - Reply. Radiology. 1995; 194:647-648.
68.	Tempany CMC, Pickett R, Seltzer SE, Getty DJ, Swets JA, Mc Neil BJ. Endorectal coil MR imaging features of advanced prostate cancer. 1995.
69.	Tempany CMC, Yang A. Magnetic resonance imaging and spectroscopy in evaluating renal allografts. Kidney Transplant Rejection: Diagnosis and Treatment. Burdick J, Racusen LC, Solez K, Williams M, eds. 1995; 487-502.
70.	Tempany CMC, Yousef N. Benign disease of the uterus. MR and Imaging of the Female Pelvis. 1995; 131-154.
71.	Tempany CMC. Medical therapy for benign prostatic hyperplasia (Commentary AJR). 1995; 164:16-17.
72.	Tempany CMC. MRI techniques and protocols. MR and Imaging of the Female Pelvis. 1995; 55-74.
73.	Tempany CMC. Normal Magnetic Resonance Imaging anatomy. MR and Imaging of the Female Pelvis. 1995; 35- 54.
74.	Tempany CMC. The use of Magnetic Resonance Imaging in cancer diagnosis. Current Therapy in Oncology. Niederhuber JE, ed. 1995.
75.	Burnett AL, Allen RP, Tempany CM, Dover GJ, Brendler CB. Evaluation of erectile function in men with sickle cell disease. Urology. 1995 Apr; 45(4):657-63.
76.	Tempany CM, Masoudi FA, Marshall FF. The use of dynamic magnetic resonance imaging to evaluate orthotopic continent urinary diversion. Urology. 1995 May; 45(5):886-92.
77.	Neish AS, Frates MC, Tempany CM. Placenta percreta post evacuation: an unusual uterine mass on MRI. J Comput Assist Tomogr. 1995 Sep-Oct; 19(5):824-7.
78.	Schwartz LH, Seltzer SE, Tempany CM, Silverman SG, Piwnica-Worms DR, Adams DF, Herman L, Herman LA, Hooshmand R. Superparamagnetic iron oxide hepatic MR imaging: efficacy and safety using conventional and fast spin-echo pulse sequences. J Magn Reson Imaging. 1995 Sep-Oct; 5(5):566-70.
79.	Silverman SG, Hillstrom MM, Doyle CJ, Tempany CM, Sica GT. Thrombophlebitic retroperitoneal collateral veins mimicking lymphadenopathy: MR and CT appearance. Abdom Imaging. 1995 Sep-Oct; 20(5):474-6.
80.	Wax JR, Tempany CM, Slowey MJ, Smith JF, Floyd RC. Second trimester uterine atony imitating ectopic pregnancy: magnetic resonance diagnosis. Mil Med. 1995 Oct; 160(10):534-5.
81.	Chako AC, Tempany CM, Zerhouni EA. Effect of slice acquisition direction on image quality in thoracic MRI. J Comput Assist Tomogr. 1995 Nov-Dec; 19(6):936-40.
82.	David V, Tempany CMC, Rein M, Mulkern RV, Jolesz F. Imaging of leiomyomas at 0.5T in an open system. 1996.
83.	Evaluation of interobserver variability in prostate MR. RSNA. 1996.
84.	MR hysterography using axial long TR with T2 weighted imaging with 3-D projections of the uterus. Royal Australian College of Radiology, 46th Annual Meeting. 1996.
85.	Rapid cardiovascular MRI. ARRS. 1996.
86.	Spiral CT in the evaluation of flank pain: overall accuracy and feature analysis. RSNA. 1996.
87.	Tello R, Jacobson F, Tempany CMC, Knapman M, Jakab MS, Kikinis R, Rizzo R. Rapid cardiovascular MRI. 1996.
88.	Tempany CMC, Fielding JR. MRI of the female pelvis. Clinical Magnetic Resonance Imaging. Robert Edelman, ed. 1996; 1432-1465.
89.	D'Amico AV, Whittington R, Malkowicz SB, Loughlin K, Schultz D, Schnall M, Tempany CM, Tomaszewski JE, Renshaw A, Wein A. An analysis of the time course of postoperative prostate-specific antigen failure in patients with positive surgical margins: implications on the use of adjuvant therapy. Urology. 1996 Apr; 47(4):538-47.
90.	Tempany CM. MR staging of prostate cancer. How we can improve our accuracy with decisions aids and optimal techniques. Magn Reson Imaging Clin N Am. 1996 Aug; 4(3):519-32.
91.	Tempany CMC, Editor. MR staging of prostate cancer: How can we improve our accuracy with decision aids and optimal techniques. Magnetic Resonance Imaging Clinics of North America; The Male Pelvis. 1996; 519-532.
92.	Zerhouni EA, Rutter C, Hamilton SR, Balfe DM, Megibow AJ, Francis IR, Moss AA, Heiken JP, Tempany CM, Aisen AM, Weinreb JC, Gatsonis C, McNeil BJ. CT and MR imaging in the staging of colorectal carcinoma: report of the Radiology Diagnostic Oncology Group II. Radiology. 1996 Aug; 200(2):443-51.
93.	Silverman SG, Pearson GD, Seltzer SE, Polger M, Tempany CM, Adams DF, Brown DL, Judy PF. Small (< or = 3 cm) hyperechoic renal masses: comparison of helical and convention CT for diagnosing angiomyolipoma. AJR Am J Roentgenol. 1996 Oct; 167(4):877-81.
94.	D'Amico AV, McGovern FT, Church PA, Tempany CMC. The staging of prostate cancer. Prostate Cancer: A multidisciplinary Guide. Kantoff PW, Wishnow KI, Loughlin KR, eds. 1997; 41-56.
95.	Dynamic contrast-enhanced magnetic resonance imaging in the assessment of malignant pleural mesothelioma. RSNA. 1997.
96.	Haimovici JBA, Tempany CMC. MR of the female pelvis: Benign disease. Applied Radiology. 1997; 26(9):7-22.
97.	Right ventricular dysplasia: Evaluation of MR imaging criteria. RSNA. 1997.
98.	Seltzer SE, Getty DJ, Tempany CM, Pickett RM, Schnall MD, McNeil BJ, Swets JA. Staging prostate cancer with MR imaging: a combined radiologist-computer system. Radiology. 1997 Jan; 202(1):219-26.
99.	Tempany CMC, Langlotz CP. Endorectal coil magnetic resonance imaging in clinically localized prostate cancer: is it accurate?. Journal of Urology. 1997; 157(4):1371-2.
100.	The role of MR in staging cervical cancer. RSNA. 1997.
101.	Tello R, Tempany CM, Chai J, Ainslie M, Adams DF. MR hysterography using axial long TR imaging with three-dimensional projections of the uterus. Comput Med Imaging Graph. 1997 Mar-Apr; 21(2):117-23.
102.	Mulkern RV, Hushek S, Fielding JR, Silverman SG, Kuhn L, Jaramillo D, Winalski C, Tempany CMC, Jolesz FA. Inner volume fast spin echo sequences for interventional MR applications. 1997.
103.	Tempany CM, Langlotz CP. Re: Endo-rectal coil magnetic resonance imaging in clinically localized prostate cancer: is it accurate? J Urol. 1997 Apr; 157(4):1371-2.
104.	Fielding JR, Fox LA, Heller H, Seltzer SE, Tempany CM, Silverman SG, Steele G. Spiral CT in the evaluation of flank pain: overall accuracy and feature analysis. J Comput Assist Tomogr. 1997 Jul-Aug; 21(4):635-8.
105.	Getty DJ, Seltzer SE, Tempany CM, Pickett RM, Swets JA, McNeil BJ. Prostate cancer: relative effects of demographic, clinical, histologic, and MR imaging variables on the accuracy of staging. Radiology. 1997 Aug; 204(2):471-9.
106.	A comparison of Magnetic Resonance Venography (MEV), venous ultrasound and venography in the diagnosis of isolated calf vein thrombosis. AUR. 1998.
107.	A software system for interventional MR guided prostate brachytherapy. ASTRO. 1998.
108.	Cheng D, Tempany CMC. MR imaging of the prostate and bladder. Seminars in Ultrasound, CT and MRI. 1998; 19(1):67-89.
109.	DiSalvo DN, Laing FC, Tempany CMC. The dysfunctional pelvis: The uterus in infertility. Goldstein SR, Benson CB. Eds. Imaging of the Infertile Couple. 1998.
110.	Magnetic resonance prostate brachytherapy: a new technique to minimize acute urological trauma. NE-AUA. 1998.
111.	MR guided prostate brachytherapy: A new approach to seed implantation. NE-AUA. 1998.
112.	Prostate brachytherapy under interventional MR guidance with real time dosimetric feedback. NE-AUA. 1998.
113.	The comparative value of duplex Doppler, CT and MR in ovarian cancer identification and staging: Correlation with surgery and pathology. A Report of the Radiology Diagnostic Oncology Group. AIUM, ARRS. 1998.
114.	Wong TZ, Silverman SG, Fielding JR, Tempany CMC, Hynynen K, Jolesz FA. Open-configuration MR imaging, intervention and surgery of the urinary tract. Urologic Clinics of North America. Guest Editor- Kevin Loughlin MD. 1998.
115.	Cheng D, Tempany CM. MR imaging of the prostate and bladder. Semin Ultrasound CT MR. 1998 Feb; 19(1):67-89.
116.	D'Amico AV, Chang E, Garnick M, Kantoff P, Jiroutek M, Tempany CM. Assessment of prostate cancer volume using endorectal coil magnetic resonance imaging: a new predictor of tumor response to neoadjuvant androgen suppression therapy. Urology. 1998 Feb; 51(2):287-92.
117.	Wong TZ, Silverman SG, Fielding JR, Tempany CM, Hynynen K, Jolesz FA. Open-configuration MR imaging, intervention, and surgery of the urinary tract. Urol Clin North Am. 1998 Feb; 25(1):113-22.
118.	D'Amico AV, Cormack R, Tempany CM, Kumar S, Topulos G, Kooy HM, Coleman CN. Real-time magnetic resonance image-guided interstitial brachytherapy in the treatment of select patients with clinically localized prostate cancer. Int J Radiat Oncol Biol Phys. 1998 Oct 1; 42(3):507-15.
119.	Zou KH, Tempany CM, Fielding JR, Silverman SG. Original smooth receiver operating characteristic curve estimation from continuous data: statistical methods for analyzing the predictive value of spiral CT of ureteral stones. Acad Radiol. 1998 Oct; 5(10):680-7.
120.	Brown DL, Zou K, Tempany CMC, Frates MC, Silverman SG, McNeil BJ, Kurtz AB. Primary versus secondary ovarian malignancy: comparison of imaging finding of the ovarian masses in the RDOG study. Radiology. 1999; (231):218.
121.	Dosimetric consequences of needle placement during MR guided brachytherapy of the prostate. RSNA. 1999.
122.	Fielding JR, Schreyer A, Tempany CM, D’Amico AV, Kumar S, Juliano K, Zou K, Kikinis R. MRI-based volume measurement of the periurethral zone of the prostate: correlation with bladder wall thickness and obstructive symptoms. 1999.
123.	Image fusion (MR/CT) for prostate gland analysis after brachytherapy. RSNA. 1999.
124.	Interventional MR guided prostate brachytherapy: Feasibility and early clinical experience. ISMRM. 1999.
125.	McTavish JD, D’Amico, Cormack R, Jolesz FA, Tempany CMC. Evaluation of interventional MRI images (0.5T) of the prostate gland compared to endorectal coil MRI images (1.5T) in men undergoing MR guided prostate brachytherapy. 1999; 1972.
126.	Silverman SGA, Lu DSK, Tempany CMC. Interventional MR Imaging: abdominal applications. RSNA categorical course in diagnostic radiology: Body MRI. 1999; 39-50.
127.	Tempany CM, Frates MC, Kumar AJ< Ward VL, Benson CB, Nadel AS. MR Evaluation of fetal anomalies of the central nervous system and genitourinary system. RSNA. 1999.
128.	Harisinghani MG, Saini S, Weissleder R, Hahn PF, Yantiss RK, Tempany C, Wood BJ, Mueller PR. MR lymphangiography using ultrasmall superparamagnetic iron oxide in patients with primary abdominal and pelvic malignancies: radiographic-pathologic correlation. AJR Am J Roentgenol. 1999 May; 172(5):1347-51.
129.	Kurtz AB, Tsimikas JV, Tempany CM, Hamper UM, Arger PH, Bree RL, Wechsler RJ, Francis IR, Kuhlman JE, Siegelman ES, Mitchell DG, Silverman SG, Brown DL, Sheth S, Coleman BG, Ellis JH, Kurman RJ, Caudry DJ, McNeil BJ. Diagnosis and staging of ovarian cancer: comparative values of Doppler and conventional US, CT, and MR imaging correlated with surgery and histopathologic analysis--report of the Radiology Diagnostic Oncology Group. Radiology. 1999 Jul; 212(1):19-27.
130.	Cheng D, Thibodeau S, Tan S, Tempany CMC. Comparison of Fast Recovery Fast Spin echo and conventional fast spin echo for T2-Weighted imaging of the prostate gland. 2000; 1436:188.
131.	Cormack RA, Kooy H, Tempany CM, D'Amico AV. A clinical method for real-time dosimetric guidance of transperineal 125I prostate implants using interventional magnetic resonance imaging. Int J Radiat Oncol Biol Phys. 2000 Jan 1; 46(1):207-14.
132.	Durfee SM, Zou KH, Muto MG, Sheets EE, Tempany CMC. The role of magnetic resonance imaging in treatment planning of cervial carcinoma. Journal of Women's Imaging. 2000; 2:63-68.
133.	Hurwitz MD, Cormack R, Tempany CMC, Kumar S, D’Amico AV. Three-dimensional real-time magnetic resonance-guided interstitial prostate brachytherapy optimizes radiation dose distribution resulting in favorable acute side-effect profile in patients with clinically localized prostate cancer. Techniques in Urology. 2000; 2:89-94.
134.	Kettenbach J, Kacher DF, Koskinen SK, Silverman SG, Nabavi A, Gering D, Tempany CM, Schwartz RB, Kikinis R, Black PM, Jolesz FA. Interventional and intraoperative magnetic resonance imaging. Annu Rev Biomed Eng. 2000; 2:661-90.
135.	Kettenbach, J, Kacher DF, Koskinen SK, Silverman SG, Nabavi A, Gering D, Tempany CMC, Schwartz RB, Kikinis R, Black PM, Jolesz FA. Interventional and intraoperative magnetic resonance imaging. Ann Rev Bioengineer. 2000; 2:661-690.
136.	Kooy HM, Cormack RA, Mathiowitz G, Tempany C, D'Amico AV. A software system for interventional magnetic resonance image-guided prostate brachytherapy. Comput Aided Surg. 2000; 5(6):401-13.
137.	Kurtz AB, Tempany CMC, Brown DL. The comparative values of Doppler/Ultrasound, Computed Tomography and Magnetic Resonance in ovarian cancer diagnosis and staging-correlation with surgery and pathology. Journal of Women's Imaging. 2000; 2(4):154-155.
138.	Three-dimensional magnetic resonance imaging of the fetal brain. ISMRM. 2000.
139.	D'Amico A, Cormack R, Kumar S, Tempany CM. Real-time magnetic resonance imaging-guided brachytherapy in the treatment of selected patients with clinically localized prostate cancer. J Endourol. 2000 May; 14(4):367-70.
140.	Hurwitz MD, Cormack R, Tempany CM, Kumar S, D'Amico AV. Three-dimensional real-time magnetic resonance-guided interstitial prostate brachytherapy optimizes radiation dose distribution resulting in a favorable acute side effect profile in patients with clinically localized prostate cancer. Tech Urol. 2000 Jun; 6(2):89-94.
141.	Tempany CM, Zou KH, Silverman SG, Brown DL, Kurtz AB, McNeil BJ. Staging of advanced ovarian cancer: comparison of imaging modalities--report from the Radiological Diagnostic Oncology Group. Radiology. 2000 Jun; 215(3):761-7.
142.	Thomas MD, Cormack R, Tempany CM, Kumar S, Manola J, Schneider L, Hurwitz MD, D'Amico AV. Identifying the predictors of acute urinary retention following magnetic-resonance-guided prostate brachytherapy. Int J Radiat Oncol Biol Phys. 2000 Jul 1; 47(4):905-8.
143.	D'Amico AV, Tempany CM, Cormack R, Hata N, Jinzaki M, Tuncali K, Weinstein M, Richie JP. Transperineal magnetic resonance image guided prostate biopsy. J Urol. 2000 Aug; 164(2):385-7.
144.	Norwitz ER, Hoyte LP, Jenkins KJ, van der Velde ME, Ratiu P, Rodriguez-Thompson D, Wilkins-Haug L, Tempany CM, Fishman SJ. Separation of conjoined twins with the twin reversed-arterial-perfusion sequence after prenatal planning with three-dimensional modeling. N Engl J Med. 2000 Aug 10; 343(6):399-402.
145.	Cormack RA, D'Amico AV, Hata N, Silverman S, Weinstein M, Tempany CM. Feasibility of transperineal prostate biopsy under interventional magnetic resonance guidance. Urology. 2000 Oct 1; 56(4):663-4.
146.	Cormack RA, Tempany CM, D'Amico AV. Optimizing target coverage by dosimetric feedback during prostate brachytherapy. Int J Radiat Oncol Biol Phys. 2000 Nov 1; 48(4):1245-9.
147.	Bayesian statistical hierarchical nonlinear regression models for ROC analysis: the accuracy of diagnostic markers for prostate cancer staging: an RDOG experience. RSNA/Radiology. 2001; (221):426.
148.	Contreras M, Thibodeau S, Sica GT, Zou K, Mulkern RV, Tempany CMC. T2-weighted MRI of the liver comparison of fast recovery fast spin echo and single shot fast spin echo sequences. 2001.
149.	D’Amico AV, Cormack RC, Tempany CMC. Endorectal coil MRI for the prostate gland. Endocavitary MRI of the Pelvis. N. DeSouza, Ed. 2001.
150.	D'Amico AV, Cormack RA, Tempany CMC. MRI-guided diagnosis and treatment of prostate cancer. New England Journal of Medicine. 2001; 433(10):776-777.
151.	MR guided prostate biopsy: Feasibility and early clinical evaluation. RSNA/Radiology. 2001; (221):260.
152.	MR imaging-guided focused ultrasound surgery of leiomyomas of the uterus: Early experience. RSNA/Radiology. 2001; (221):260.
153.	Schierlitz L, Tempany CMC. MRI in Obstetrics. Educational supplement sponsored by Healthcare Education Products and CME Inc. 2001.
154.	Three dimensional modeling and volume assessment of fetal and neonatal intracranial ventricles. ISMRM. 2001.
155.	Three-dimensional finite element-based deformable registration of pre- and intraoperative prostate imaging. RSNA/Radiology. 2001.
156.	Tsai A, Yezzi A, Wells W, Tempany CMC, Tuckers D, Fan A, Griimson WE, Willsky A. Model-based curve evolution technique for image segmentation. 2001; 1:463-468.
157.	Tempany CM, McNeil BJ. Advances in biomedical imaging. JAMA. 2001 Feb 7; 285(5):562-7.
158.	D'Amico AV, Cormack RA, Tempany CM. MRI-guided diagnosis and treatment of prostate cancer. N Engl J Med. 2001 Mar 8; 344(10):776-7.
159.	Brown DL, Zou KH, Tempany CM, Frates MC, Silverman SG, McNeil BJ, Kurtz AB. Primary versus secondary ovarian malignancy: imaging findings of adnexal masses in the Radiology Diagnostic Oncology Group Study. Radiology. 2001 Apr; 219(1):213-8.
160.	Schierlitz L, Dumanli H, Robinson JN, Burrows PE, Schreyer AG, Kikinis R, Jolesz FA, Tempany CM. Three-dimensional magnetic resonance imaging of fetal brains. Lancet. 2001 Apr 14; 357(9263):1177-8.
161.	Hata N, Jinzaki M, Kacher D, Cormak R, Gering D, Nabavi A, Silverman SG, D'Amico AV, Kikinis R, Jolesz FA, Tempany CM. MR imaging-guided prostate biopsy with surgical navigation software: device validation and feasibility. Radiology. 2001 Jul; 220(1):263-8.
162.	Omalley AJ, Zou KH, Fielding JR, Tempany CM. Bayesian regression methodology for estimating a receiver operating characteristic curve with two radiologic applications: prostate biopsy and spiral CT of ureteral stones. Acad Radiol. 2001 Aug; 8(8):713-25.
163.	Sica GT, Pugach ME, Koniaris LS, Goldhaber SZ, Polak JF, Mukerjee A, Tempany CM. Isolated calf vein thrombosis: comparison of MR venography and conventional venography after initial sonography in symptomatic patients. Acad Radiol. 2001 Sep; 8(9):856-63.
164.	Tempany CMC. Radiation Seed Implant Method and Apparatus. 2001.
165.	Bharatha A, Hirose M, Hata N, Warfield SK, Ferrant M, Zou KH, Suarez-Santana E, Ruiz-Alzola J, D'Amico A, Cormack RA, Kikinis R, Jolesz FA, Tempany CM. Evaluation of three-dimensional finite element-based deformable registration of pre- and intraoperative prostate imaging. Med Phys. 2001 Dec; 28(12):2551-60.
166.	D'Amico AV, Manola J, Loffredo M, Lopes L, Nissen K, O'Farrell DA, Gordon L, Tempany CM, Cormack RA. A practical method to achieve prostate gland immobilization and target verification for daily treatment. Int J Radiat Oncol Biol Phys. 2001 Dec 1; 51(5):1431-6.
167.	Robinson JN, Norwitz ER, Mulkern R, Brown SA, Rybicki F, Tempany CM. Prenatal diagnosis of pyruvate dehydrogenase deficiency using magnetic resonance imaging. Prenat Diagn. 2001 Dec; 21(12):1053-6.
168.	A statistical comparison of multi-parametric MR for prostate cancer. RSNA/Radiology. 2002.
169.	Tempany CMC. MRI of the Prostate Gland. The Experts Guide to Efficacious MR. 2002; 2:10-12.
170.	Hirose M, Bharatha A, Hata N, Zou KH, Warfield SK, Cormack RA, D'Amico A, Kikinis R, Jolesz FA, Tempany CM. Quantitative MR imaging assessment of prostate gland deformation before and during MR imaging-guided brachytherapy. Acad Radiol. 2002 Aug; 9(8):906-12.
171.	Das P, Chen MH, Valentine K, Lopes L, Cormack RA, Renshaw AA, Tempany CM, Kumar S, D'Amico AV. Using the magnitude of PSA bounce after MRI-guided prostate brachytherapy to distinguish recurrence, benign precipitating factors, and idiopathic bounce. Int J Radiat Oncol Biol Phys. 2002 Nov 1; 54(3):698-702.
172.	D'Amico AV, Toupless G, Lopes L, Valentine KJ, Cormack RA, Tempany CM, Kumar S, Marks PJ. Self-administration of untested medical therapy for treatment of prostate cancer can lead to clinically significant adverse events. Int J Radiat Oncol Biol Phys. 2002 Dec 1; 54(5):1311-3.
173.	Delineation and registration of neurovascular bundles using pre- and post-magnetic resonance guided prostate brachytherapy images. RSNA/Radiology. 2003.
174.	Fan A, Wells W, Fihser JW, Cetin M, Haker S, Mulkern R, Tempany C, Willsky AS. A unified variational approach to denoising and bias correction in MR. 2003.
175.	Mortele KJ, Tuncali K, Cantisani V, Shankar S, vanSonnenberg E, Tempany CM, Silverman SG. (Invited Review). MRI-guided abdominal intervention. Abdominal Imaging. 2003; 28:756-774.
176.	Silberstein T, Tempany CMC, Stewart EA. MRI-guided focused ultrasound: novel therapy for leiomyomata. Contemporary OB/GYN. 2003; 22-30.
177.	Tempany CM, Fennessy F, Stewart E (Invited Review). MR-guided focused ultrasound surgery of uterine leiomyomas. Journal of Women’s Imaging. 2003; 5(4):171-176.
178.	Tempany CMC, Haker S. Magnetic resonance – guided prostate biopsy. Image-Guided Diagnosis and Treatment of Cancer. D’ Amico AV, Loeffler JS, Harris JR, Ed. 2003; 35-52.
179.	Zou KH, Fielding JR, Silverman SG, Tempany CM. Hypothesis testing I: proportions. Radiology. 2003 Mar; 226(3):609-13.
180.	Tsai A, Yezzi A, Wells W, Tempany C, Tucker D, Fan A, Grimson WE, Willsky A. A shape-based approach to the segmentation of medical imagery using level sets. IEEE Trans Med Imaging. 2003 Feb; 22(2):137-54.
181.	Planning, simulation and assistance with intraoperative MRI. Minim Invasive Ther Allied Technol. 2003 Mar; 12(1):59-64.
182.	Tempany CM, Stewart EA, McDannold N, Quade BJ, Jolesz FA, Hynynen K. MR imaging-guided focused ultrasound surgery of uterine leiomyomas: a feasibility study. Radiology. 2003 Mar; 226(3):897-905.
183.	Fan A, Wells WM, Fisher JW, Cetin M, Haker S, Mulkern R, Tempany C, Willsky AS. A unified variational approach to denoising and bias correction in MR. Inf Process Med Imaging. 2003 Jul; 18:148-59.
184.	Stewart EA, Gedroyc WM, Tempany CM, Quade BJ, Inbar Y, Ehrenstein T, Shushan A, Hindley JT, Goldin RD, David M, Sklair M, Rabinovici J. Focused ultrasound treatment of uterine fibroid tumors: safety and feasibility of a noninvasive thermoablative technique. Am J Obstet Gynecol. 2003 Jul; 189(1):48-54.
185.	Tsai A, Wells W, Tempany C, Grimson E, Willsky A. Coupled multi-shape model and mutual information for medical image segmentation. Inf Process Med Imaging. 2003 Jul; 18:185-97.
186.	Albert M, Tempany CM, Schultz D, Chen MH, Cormack RA, Kumar S, Hurwitz MD, Beard C, Tuncali K, O'Leary M, Topulos GP, Valentine K, Lopes L, Kanan A, Kacher D, Rosato J, Kooy H, Jolesz F, Carr-Locke DL, Richie JP, D'Amico AV. Late genitourinary and gastrointestinal toxicity after magnetic resonance image-guided prostate brachytherapy with or without neoadjuvant external beam radiation therapy. Cancer. 2003 Sep 1; 98(5):949-54.
187.	Anzai Y, Piccoli CW, Outwater EK, Stanford W, Bluemke DA, Nurenberg P, Saini S, Maravilla KR, Feldman DE, Schmiedl UP, Brunberg JA, Francis IR, Harms SE, Som PM, Tempany CM. Evaluation of neck and body metastases to nodes with ferumoxtran 10-enhanced MR imaging: phase III safety and efficacy study. Radiology. 2003 Sep; 228(3):777-88.
188.	Cantisani V, Mortele KJ, Kalantari BN, Glickman JN, Tempany C, Silverman SG. Vaginal metastasis from uterine leiomyosarcoma. Magnetic resonance imaging features with pathological correlation. J Comput Assist Tomogr. 2003 Sep-Oct; 27(5):805-9.
189.	Chan I, Wells W, Mulkern RV, Haker S, Zhang J, Zou KH, Maier SE, Tempany CM. Detection of prostate cancer by integration of line-scan diffusion, T2-mapping and T2-weighted magnetic resonance imaging; a multichannel statistical classifier. Med Phys. 2003 Sep; 30(9):2390-8.
190.	Sanghani MV, Schultz D, Tempany CM, Titelbaum D, Renshaw AA, Loffredo M, Cote K, McMahon B, D'Amico AV. Quantifying the change in endorectal magnetic resonance imaging-defined tumor volume during neoadjuvant androgen suppression therapy in patients with prostate cancer. Urology. 2003 Sep; 62(3):487-91.
191.	Mortele KJ, Tuncali K, Cantisani V, Shankar S, vanSonnenberg E, Tempany C, Silverman SG. MRI-guided abdominal intervention. Abdom Imaging. 2003 Nov-Dec; 28(6):756-74.
192.	D'amico AV, Tempany CM, Schultz D, Cormack RA, Hurwitz M, Beard C, Albert M, Kooy H, Jolesz F, Richie JP. Comparing PSA outcome after radical prostatectomy or magnetic resonance imaging-guided partial prostatic irradiation in select patients with clinically localized adenocarcinoma of the prostate. Urology. 2003 Dec; 62(6):1063-7.
193.	Zou KH, Warfield SK, Fielding JR, Tempany CM, William MW, Kaus MR, Jolesz FA, Kikinis R. Statistical validation based on parametric receiver operating characteristic analysis of continuous classification data. Acad Radiol. 2003 Dec; 10(12):1359-68.
194.	A Comparison Between Affine and Rigid MR and CT Registrations for Prostate Brachytherapy Dosimetry. RSNA. 2004.
195.	Bootstrap and Jackknife Goodness-of-Fit Tests for Receiver Operating Characteristic Curves Derived From Continuous Diagnostic Test Data. RSNA. 2004.
196.	Dickhaus CF, Burghart C, Tempany C, D'Amico A, Haker S, Kikinis R, Woern H. Workflow modeling and analysis of computer guided prostate brachytherapy under MR imaging control. Stud Health Technol Inform. 2004; 98:72-4.
197.	Effectiveness of MR-guided Focused Ultrasound Surgery Treated Uterine Leiomyomas Correlated With Menstrual Cycle Phase. RSNA. 2004.
198.	J N Glantz, MD; G K Hesley, MD; K R Brandt, MD; J P Felmlee, PhD; D L Brown, MD C M Tempany, MD; M J So, MD. Utilization of MR Imaging for the Selection of Patients for MR-guided Focused Ultrasound Surgery of Uterine Fibroids. 2004.
199.	Six Months Post MR-guided Focused Ultrasound Surgery of Uterine Leiomyomas: Correlation of Volume Change With Non-Perfusion Treatment Volume and Sonication Number. RSNA. 2004.
200.	Szot A, Tempany CMC. Image guided minimally invasive therapy. Urologic Oncology. D’Amico AV, Richie J, Ed. 2004.
201.	Warfield SK, Zou KH, Wells SM. Simultaneous truth and performance level estimation(STAPLE): an algorithm for the validation of image segmentation. IEEE Trans Med Imaging. 2004; 23(7):903-21.
202.	Zou KH, Warfield SK, Bharatha A, Tempany CM, Kaus MR, Haker SJ, Wells WM, Jolesz FA, Kikinis R. Statistical validation of image segmentation quality based on a spatial overlap index. Acad Radiol. 2004 Feb; 11(2):178-89.
203.	Nguyen PL, Whittington R, Koo S, Schultz D, Cote KB, Loffredo M, Tempany CM, Titelbaum DS, Schnall MD, Renshaw AA, Tomaszewski JE, D'Amico AV. Quantifying the impact of seminal vesicle invasion identified using endorectal magnetic resonance imaging on PSA outcome after radiation therapy for patients with clinically localized prostate cancer. Int J Radiat Oncol Biol Phys. 2004 Jun 1; 59(2):400-5.
204.	Frates MC, Kumar AJ, Benson CB, Ward VL, Tempany CM. Fetal anomalies: comparison of MR imaging and US for diagnosis. Radiology. 2004 Aug; 232(2):398-404.
205.	Mulkern RV, Rybicki FJ, Haker SJ, Tempany CM. Comments on T2 measurements of prostate tissue. Radiology. 2004 Aug; 232(2):624-5; author reply 625-6.
206.	Robinson JN, Cleary-Goldman J, Arias-Mendoza F, Cruz-Lobo J, Tempany C, Mulkern RV, Feinberg BB, Brown TR. Detection of fetal lactate with two-dimensional-localized proton magnetic resonance spectroscopy. Obstet Gynecol. 2004 Nov; 104(5 Pt 2):1208-10.
207.	Hindley J, Gedroyc WM, Regan L, Stewart E, Tempany C, Hynyen K, Hynnen K, Mcdannold N, Macdanold N, Inbar Y, Itzchak Y, Rabinovici J, Kim HS, Kim K, Geschwind JF, Hesley G, Gostout B, Gostout B, Ehrenstein T, Hengst S, Sklair-Levy M, Shushan A, Jolesz F. MRI guidance of focused ultrasound therapy of uterine fibroids: early results. AJR Am J Roentgenol. 2004 Dec; 183(6):1713-9.
208.	Tsai A, Wells W, Tempany C, Grimson E, Willsky A. Mutual information in coupled multi-shape model for medical image segmentation. Med Image Anal. 2004 Dec; 8(4):429-45.
209.	Warfield SK, Haker SJ, Talos IF, Kemper CA, Weisenfeld N, Mewes AU, Goldberg-Zimring D, Zou KH, Westin CF, Wells WM, Tempany CM, Golby A, Black PM, Jolesz FA, Kikinis R. Capturing intraoperative deformations: research experience at Brigham and Women's Hospital. Med Image Anal. 2005 Apr; 9(2):145-62.
210.	Albert M, Song JS, Schultz D, Cormack R, Tempany-Afdhal C, Szot-Barnes A, Beard C, Hurwitz M, Suh W, Jolesz F, D'Amico AV. Defining the rectal dose constraint for permanent radioactive seed implantantion of the prostate. Internarional Journal of Radiation Oncology, Biology and Physics. 2005; 63(2):S300.
211.	Clinical Evaluation of MR-guided Prostate Biopsy. ISMRM. 2005.
212.	Evaluation of Symptom Relief and Fibroid Reduction 1 Year Following MR guided Focused Ultrasound Surgery. RSNA. 2005.
213.	Evaluation of the Safety and Efficacy of a Continued Access Study for MR-guided Focused Ultrasound Surgery (MRgFUS) of Uterine Fibroids. RSNA. 2005.
214.	Jolesz Ferenc A., Hynynen K, McDannold N, Tempany C . MR Imaging-Controlled Focused Ultrasound Ablation: A Noninvasive Image Guided Surgery. Magnetic Resonance Imaging Clinics of North America. 2005; 545-560.
215.	Minna J. So, Steven Haker, Kelly H. Zou, Agnieszka Szot Barnes, Robert Cormack, Jerome Richie, Anthony V. D’Amico, Clare M.Tempany. Clinical Evaluation of MR-Guided Prostate Biopsy. 2005.
216.	S J Haker; A Szot Barnes; S E Maier; C M Tempany. R V Mulkern Diffusion Tensor Imaging for Prostate Cancer Detection: Preliminary Results From a Biopsy-Based Assessment. 2005.
217.	Tempany CMC, Stewart EA, Hynynen K, McDannold N. Focused Ultrasound for Tumor Ablation. Tumor Ablation: Principles and Practice. van Sonnenberg E, McMullen W, Eds. 2005; 273-284.
218.	Treatment Outcome in MR-guided Focused Ultrasound Surgery (MRgFUS) for Uterine Fibroids: Analysis of the Effect of Baseline Uterine Size and Number of Fibroids. RSNA/ISTU. 2005.
219.	Landis DM, Schultz D, Cormack R, Tempany C, Beard C, Hurwitz M, O'Leary M, Albert M, Valentine K, D'Amico AV. Acute urinary retention after magnetic resonance image-guided prostate brachytherapy with and without neoadjuvant external beam radiotherapy. Urology. 2005 Apr; 65(4):750-4.
220.	Febbo PG, Richie JP, George DJ, Loda M, Manola J, Shankar S, Barnes AS, Tempany C, Catalona W, Kantoff PW, Oh WK. Neoadjuvant docetaxel before radical prostatectomy in patients with high-risk localized prostate cancer. Clin Cancer Res. 2005 Jul 15; 11(14):5233-40.
221.	Jolesz FA, Hynynen K, McDannold N, Tempany C. MR imaging-controlled focused ultrasound ablation: a noninvasive image-guided surgery. Magn Reson Imaging Clin N Am. 2005 Aug; 13(3):545-60.
222.	Fennessy FM, Tempany CM. MRI-guided focused ultrasound surgery of uterine leiomyomas. Acad Radiol. 2005 Sep; 12(9):1158-66.
223.	Haker SJ, Mulkern RV, Roebuck JR, Barnes AS, Dimaio S, Hata N, Tempany CM. Magnetic resonance-guided prostate interventions. Top Magn Reson Imaging. 2005 Oct; 16(5):355-68.
224.	Barnes AS, Haker SJ, Mulkern RV, So M, D'Amico AV, Tempany CM. Magnetic resonance spectroscopy-guided transperineal prostate biopsy and brachytherapy for recurrent prostate cancer. Urology. 2005 Dec; 66(6):1319.
225.	Albert, Michele; Hurwitz, Mark; Beard, Clair; Tempany, Clare M; Cormack, Robert; D’Amico, Anthony. Magnetic Resonance Image-Guided Partial Prostatic Irradiation in Select Patients With Clinically Localized Adenocarcinoma of the Prostate. Practical Brachytherapy: Applications and Techniques, Devlin Ed. 2006.
226.	Ascher SM, SiewertB, Troiano R, Tempany C, Reinhold C. Female pelvis: benign vaginal, uterine and ovarian conditions. In: Edelman RR, Hesselink JR, Zlatkin MB, Crues JV III, eds. Clinical magnetic resonance imaging. 2006.
227.	DiMaio SP, Pieper S, Chinzei K, Hata N, Balogh E, Fichtinger G, Tempany CM, Kikinis R. Robot-assisted needle placement in open-MRI: system architecture, integration and validation. Stud Health Technol Inform. 2006; 119:126-31.
228.	Hata N, Blumenfeld P, DiMaio S, Zou K, Haker S, Tempany CmC. Needle Placement Accuracy in MRI-Guidwed Prostate Biopsy of Prostate Cancer. 2006.
229.	Hata N, Blumenfeld P, DiMaio S, Zou KH, Haker S, Tempany CMC. Needle Placement Accuracy in MRI- Guided Prostate Biopsy of Prostate Cancer. ISMRM. 2006; 294.
230.	Stewart EA, Rabinovici J, Tempany CM, Inbar Y, Regan L, Gostout B, Gastout B, Hesley G, Kim HS, Hengst S, Gedroyc WM, Gedroye WM. Clinical outcomes of focused ultrasound surgery for the treatment of uterine fibroids. Fertil Steril. 2006 Jan; 85(1):22-9.
231.	Szot Barnes A, Haker SJ, Maier SE, Tempany CM, Mulkern RV. Decreased diffusion coefficients in suspected prostate cancer regions in peripheral zone: A comparison with increased (Cho+Cr)/Cr ratios from MRS. 2006.
232.	Szot Barnes A, Haker SJ, Maier SE, Tempany CM, Mulkern RV. Decreased diffusion coefficients in suspected prostate cancer regions in peripheral zone: A comparison with increased (Cho+Cr)/Cr ratios from MRS. ISMRM. 2006.
233.	DiMaio SP, Fischer GS, Haker SJ, Hata N, Iordachita I, Tempany CM, Kikinis R, Fichtinger G. International Conference on Biomedical Robotics and Biomechatronics. 2006.
234.	Sodickson A, Mortele KJ, Barish MA, Zou KH, Thibodeau S, Tempany CM. Three-dimensional fast-recovery fast spin-echo MRCP: comparison with two-dimensional single-shot fast spin-echo techniques. Radiology. 2006 Feb; 238(2):549-59.
235.	Mulkern RV, Barnes AS, Haker SJ, Hung YP, Rybicki FJ, Maier SE, Tempany CM. Biexponential characterization of prostate tissue water diffusion decay curves over an extended b-factor range. Magn Reson Imaging. 2006 Jun; 24(5):563-8.
236.	Roebuck JR, Haker SJ, Tempany CM, Rybicki FJ, Maier SE, Mulkern RV. Diffusion Tensor Imaging of the Prostate: Low Anisotropies in Central Gland and Peripheral Zone in Men with Adenocarcinoma. ISMRM. 2006.
237.	Fennessy FM, Tempany CM. A review of magnetic resonance imaging-guided focused ultrasound surgery of uterine fibroids. Top Magn Reson Imaging. 2006 Jun; 17(3):173-9.
238.	Xiong L, Viswanathan A, Stewart AJ, Haker S, Tempany CM, Chin LM, Cormack RA. Deformable structure registration of bladder through surface mapping. Med Phys. 2006 Jun; 33(6):1848-56.
239.	McDannold N, Tempany CM, Fennessy FM, So MJ, Rybicki FJ, Stewart EA, Jolesz FA, Hynynen K. Uterine leiomyomas: MR imaging-based thermometry and thermal dosimetry during focused ultrasound thermal ablation. Radiology. 2006 Jul; 240(1):263-72.
240.	Viswanathan AN, Cormack R, Holloway CL, Tanaka C, O'Farrell D, Devlin PM, Tempany C. Magnetic resonance-guided interstitial therapy for vaginal recurrence of endometrial cancer. Int J Radiat Oncol Biol Phys. 2006 Sep 1; 66(1):91-9.
241.	So MJ, Fennessy FM, Zou KH, McDannold N, Hynynen K, Jolesz FA, Stewart EA, Rybicki FJ, Tempany CM. Does the phase of menstrual cycle affect MR-guided focused ultrasound surgery of uterine leiomyomas? Eur J Radiol. 2006 Aug; 59(2):203-7.
242.	Nain D, Haker SJ, Bobick A, Tannenbaum A. Shape-driven surface segmentation using spherical wavelets. 2006.
243.	DiMaio SP, Pieper S, Chinzei K, Hata N, Haker SJ, Kacher DF, Fichtinger G, Tempany CM, Kikinis R. Robot-assisted needle placement in open MRI: system architecture, integration and validation. Comput Aided Surg. 2007 Jan; 12(1):15-24.
244.	Gessman R, Tempany CM, McDannold N. Predicted prostate cooling from a water cooled focused ultrasound rectal probe utilizing MRI dynamic contrast enhanced perfusion measurements. RSNA. 2007.
245.	Hanstede M, Stewart EA, Tempany CM. MRgFocused ultrasound surgery for uterine fibroids. MRgFUS. Hynynen K & Jolesz FA, eds. 2007.
246.	Kelloff GJ, Sullivan DC, Baker H, Clarke LP, Nordstrom R, Tatum JL, Dorfman GS, Jacobs P, Berg CD, Pomper MG, Birrer MJ, Tempero M, Higley HR, Petty BG, Sigman CC, Maley C, Sharma P, Wax A, Ginsberg GG, Dannenberg AJ, Hawk ET, Messing EM, Grossman HB, Harisinghani M, Bigio IJ, Griebel D, Henson DE, Fabian CJ, Ferrara K, Fantini S, Schnall MD, Zujewski JA, Hayes W, Klein EA, DeMarzo A, Ocak I, Ketterling JA, Tempany C, Shtern F, Parnes HL, Gomez J, Srivastava S, Szabo E, Lam S, Seibel EJ, Massion P, McLennan G, Cleary K, Suh R, Burt RW, Pfeiffer RM, Hoffman JM, Roy HK, Wang T, Limburg PJ, El-Deiry WS, Papadimitrakopoulou V, Hittelman WN, MacAulay C, Veltri RW, Solomon D, Jeronimo J, Richards-Kortum R, Johnson KA, Viner JL, Stratton SP, Rajadhyaksha M, Dhawan A. Workshop on imaging science development for cancer prevention and preemption. Cancer Biomark. 2007; 3(1):1-33.
247.	Lenard ZM, McDannold N, Fennessy F, Stewart EA, Jolesz F, Hynynen K, Tempany CM. Predictors of Success in MRI-Guided Focused Ultrasound Therapy of Uterine Leiomyomas. Proc. Intl. Soc. Mag. Reson. Med. 2007; 15:157.
248.	McDannold N, Hynynen K, Tempany C, Jolesz F. . Evaluation of Referenceless Thermometry in MRI-guided Focused Ultrasound Surgery of Uterine Fibroids. JMRI. 2007.
249.	Roebuck JR, Mirsouras D, Haker SJ, Rybicki FJ, Tempany CM, Mulkern RV. Carr-Purcell-Meiboom-Gill (CPMG) imaging of prostate cancer; Trading time for information; High quality T2 images and quantitative T2 values for cancer discrimination. 2007.
250.	Roebuck JR, Mirsouras D, Haker SJ, Rybicki FJ, Tempany CM, Mulkern RV. Carr-Purcell-Meiboom-Gill (CPMG) imaging of prostate cancer; Trading time for information; High quality T2 images and quantitative T2 values for cancer discrimination. ISMRM. 2007.
251.	Tempany C, Hata N, Haker S, Straus S. MR Guided Prostate Interventions. Interventional MRI Update. 2007; IN PRINT .
252.	Tempany CM. The Crawford/Barqawi Article Reviewed: Targeted Focal Therapy: A Minimally Invasive Ablation Technique for Early Prostate Cancer. Oncology. 2007; Volume 21, Number 1(January 2007):34.
253.	Wong PYH, Hata N, Szot Barnes A, Haker S, Zou K, D'Amico A, Tempany CMC. Displacement of neurovascular bundles before and after MRI-guided prostate brachytherapy. ISMRM. 2007.
254.	Wong PYH, Hata N, Szot Barnes A, Zou K, D'Amico A, Tempany CMC. Displacement of neurovascular bundles before and after MRI-guided prosate brachytherapy. 2007.
255.	Hanstede MM, Tempany CM, Stewart EA. Focused ultrasound surgery of intramural leiomyomas may facilitate fertility: a case report. Fertil Steril. 2007 Aug; 88(2):497.e5-7.
256.	Fennessy FM, Tempany CM, McDannold NJ, So MJ, Hesley G, Gostout B, Kim HS, Holland GA, Sarti DA, Hynynen K, Jolesz FA, Stewart EA. Uterine leiomyomas: MR imaging-guided focused ultrasound surgery--results of different treatment protocols. Radiology. 2007 Jun; 243(3):885-93.
257.	Zhang JQ, Loughlin KR, Zou KH, Haker S, Tempany CM. Role of endorectal coil magnetic resonance imaging in treatment of patients with prostate cancer and in determining radical prostatectomy surgical margin status: report of a single surgeon's practice. Urology. 2007 Jun; 69(6):1134-7.
258.	Stewart EA, Gostout B, Rabinovici J, Kim HS, Regan L, Tempany CM. Sustained relief of leiomyoma symptoms by using focused ultrasound surgery. Obstet Gynecol. 2007 Aug; 110(2 Pt 1):279-87.
259.	Blumenfeld P, Hata N, DiMaio S, Zou K, Haker S, Fichtinger G, Tempany CM. Transperineal prostate biopsy under magnetic resonance image guidance: a needle placement accuracy study. J Magn Reson Imaging. 2007 Sep; 26(3):688-94.
260.	Nguyen PL, Chen MH, D'Amico AV, Tempany CM, Steele GS, Albert M, Cormack RA, Carr-Locke DL, Bleday R, Suh WW. Magnetic resonance image-guided salvage brachytherapy after radiation in select men who initially presented with favorable-risk prostate cancer: a prospective phase 2 study. Cancer. 2007 Oct 1; 110(7):1485-92.
261.	Fischer G, Iordachita I, Csoma C, Tokuda J, Mewes P, Tempany C, Hata N, Fichtinger G. Pneumatically Operated MRI-Compatible Needle Placement Robot for Prostate Interventions. 2008 IEEE International Conference on Robotics and Automation. 2008.
262.	Zsuzsanna M. Földes-Lénárd MD PhD Nathan McDannold PhD, Fiona M. Fennessy MD PhD Elizabeth A. Stewart MD Ferenc A. Jolesz MD Kullervo Hynynen PhD Clare Tempany MD . Uterine Leiomyomas: MR imaging-guided Focused Ultrasound Surgery-Imaging predictors of Success. Radiology. 2008; 249(1):187-194.

 

Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact Human Resources at faculty_serviceshms.harvard.edu.

Tempany-Afdhal's...